A case asking whether insurers and pharmacy benefit managers face ERISA liability when negotiating drug prices doesn’t merit US Supreme Court review, according to a federal government brief advising the justices to skip a case involving
The US Court of Appeals for the Second Circuit’s 2020 decision declining to hold either company liable as a fiduciary under the Employee Retirement Income Security Act is a nonprecedential ruling that doesn’t conflict with any Supreme Court or appeals court decisions, US Solicitor General Elizabeth B. Prelogar told the justices in a brief filed Tuesday.
However Prelogar’s ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
